Timothy Rolph
CIK 1779479 · Chief Scientific Officer · last filed 2025-12-09
Timothy Rolph is a Chief Scientific Officer who has filed 47 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for AKRO, was dated Dec 9, 2025. Across all open-market trades the lifetime net is −$19.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
47
-$19.56M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Scientific Officer | 0 | $54.65 | $0 | -$19.56M | 47 | 2025-12-09 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Disp (D) | −282,149 | $0 | EDGAR |
| 2025-11-28 | Akero Therapeutics, Inc. (AKRO) Delisted | Exer (M) | +152,678 | $624.1K | EDGAR |
| 2025-11-19 | Akero Therapeutics, Inc. (AKRO) Delisted | Gift (G) | −37,100 | $0 | EDGAR |
| 2025-10-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$221.6K | EDGAR |
| 2025-09-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −553 | -$23.8K | EDGAR |
| 2025-09-10 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$362.4K | EDGAR |
| 2025-08-07 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$352.7K | EDGAR |
| 2025-07-09 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$375.0K | EDGAR |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +890 | $21.2K | EDGAR |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −1,129 | -$61.9K | EDGAR |